Search
Close this search box.

Gene Therapy Trial Evaluates Efficacy of Cancer-Targeting Virus in Treating Brain Tumors

**Gene Therapy Trial Evaluates Efficacy of Cancer-Targeting Virus in Treating Brain Tumors** In the ever-evolving landscape of cancer treatment, gene...

### 2024 PRP Randomized Controlled Trial Infographic 2.0 by Regenexx: A Comprehensive Overview In the ever-evolving field of regenerative medicine,...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: Histological and Biochemical...

**Comparative Analysis of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and Biochemical Study –...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and...

**Jonathan Thomas Appointed as New President and CEO of CIRM** In a significant development for the field of regenerative medicine,...

# $53 Million Allocated for Clinical and Translational Research Funding: A Leap Forward in Medical Innovation In a significant move...

**Correction Notice: Influence of Thyroid Hormone Receptor β on Cancer Stem Cell Activity – Oncogene** In the ever-evolving field of...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Implications for Cell Death and Disease** The human...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Insights from Cell Death & Disease** Human epidermal...

**Nevada Approves Controversial Unproven Therapies, Joining Other States in Challenging FDA Regulations on Biologics** In a move that has sparked...

**QC Kinetix Shifts Focus from Upselling to Cost Reduction – Regenexx Reports** In the ever-evolving landscape of regenerative medicine, QC...

# Effective Approaches for Modeling Aging and Age-Related Diseases Aging is an inevitable biological process that affects all living organisms....

**Infographic on the 2024 PRP Randomized Controlled Trial by Regenexx: A Comprehensive Overview** In the ever-evolving field of regenerative medicine,...

# Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Advancement – Insights from Signal Transduction and Targeted Therapy...

**Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Progression – Insights from Signal Transduction and Targeted Therapy** Hepatocellular...

**Lung Institute Stem Cell Clinic Ordered to Pay $9 Million in Class Action Lawsuit Settlement** In a landmark decision, the...

# Improvement of Endothelial Function and Reduction of Portal Vein Injury with miRNA-25-3p-Expressing Mesenchymal Stem Cells – Scientific Reports ##...

**Innovative Stem Cell Therapy for Treating Cystic Fibrosis-Related Sinusitis** Cystic fibrosis (CF) is a genetic disorder that primarily affects the...

**Innovative Stem Cell Therapy for Treating Sinusitis in Cystic Fibrosis Patients** Cystic fibrosis (CF) is a genetic disorder that primarily...

**Cytosolic N-terminal Formyl-Methionine Deformylation Promotes Cancer Stem Cell Characteristics and Tumor Progression** Cancer remains one of the most formidable challenges...

**Deformylation of Cytosolic N-terminal Formyl-Methionine Promotes Cancer Stem Cell Characteristics and Tumor Progression – Scientific Reports** Cancer remains one of...

**miR-124-3p Reduces EGR1 Expression to Mitigate Ischemia-Hypoxia Reperfusion Injury in Human iPS Cell-Derived Cardiomyocytes – Scientific Reports** Ischemia-hypoxia reperfusion injury...

**miR-124-3p Suppresses Ischemia-Hypoxia Reperfusion Injury in Human iPS Cell-Derived Cardiomyocytes by Downregulating EGR1 – Scientific Reports** Ischemia-hypoxia reperfusion (IHR) injury...

**Lack of Response from FDA Commissioner Robert Califf on Stem Cell Clinics Raises Concerns** In recent years, the burgeoning field...

# Uniting the Community: Highlights from the 2nd Annual ALSP Conference The 2nd Annual Alternative Legal Service Providers (ALSP) Conference,...

**Uniting the Community at the 2nd Annual ALSP Conference** In an era where legal innovation is rapidly transforming the landscape...

**Pioneering 3D Brain Models Incorporate Cells from Multiple Donors: A Leap Forward in Neuroscience** In the ever-evolving field of neuroscience,...

**First-of-Their-Kind 3D Brain Models Incorporate Cells from Multiple Donors: A Leap Forward in Neuroscience** In a groundbreaking advancement for neuroscience,...

**Chimeric Brain Organoids Reflect the Spectrum of Human Genetic Diversity** In recent years, the field of neuroscience has witnessed groundbreaking...

How Mesenchymal Glioma Stem Cells Induce Vasectasia through Extracellular Vesicles Carrying EGFR: A Study in Nature Communications

A recent study published in Nature Communications has shed light on the role of mesenchymal glioma stem cells in inducing vasculature abnormalities, known as vasectasia, through the release of extracellular vesicles carrying epidermal growth factor receptor (EGFR). This groundbreaking research provides new insights into the mechanisms underlying the development of vasculature abnormalities in glioblastoma, a highly aggressive form of brain cancer.

Glioblastoma is characterized by its ability to invade surrounding brain tissue and form new blood vessels to support its growth. Mesenchymal glioma stem cells have been identified as a key player in promoting tumor progression and resistance to therapy. In this study, researchers investigated how these stem cells contribute to the formation of abnormal blood vessels in the tumor microenvironment.

The researchers found that mesenchymal glioma stem cells release extracellular vesicles containing EGFR, a protein that plays a critical role in promoting cell proliferation and survival. These extracellular vesicles were taken up by endothelial cells, which line the blood vessels, leading to increased expression of EGFR and activation of downstream signaling pathways.

The activation of EGFR signaling in endothelial cells resulted in increased vascular permeability and abnormal vessel formation, ultimately leading to vasectasia. This process not only promotes tumor growth and invasion but also hinders the delivery of therapeutic agents to the tumor site, making treatment more challenging.

The findings of this study have important implications for the development of new therapeutic strategies for glioblastoma. Targeting mesenchymal glioma stem cells or blocking EGFR signaling in endothelial cells could potentially inhibit the formation of abnormal blood vessels and improve the efficacy of existing treatments.

Overall, this study highlights the complex interplay between mesenchymal glioma stem cells, extracellular vesicles, and EGFR signaling in promoting vasculature abnormalities in glioblastoma. By unraveling these mechanisms, researchers are one step closer to developing more effective therapies for this devastating disease.